Bidirectional glenn shunt surgery using lepirudin anticoagulation in an infant with heparin-induced thrombocytopenia...

Area of Science:

• Cardiovascular Surgery
• Pediatric Cardiology
• Hematology

Background:

• Heparin-induced thrombocytopenia (HIT) is a serious immune-mediated complication of heparin therapy.
• Management of HIT in pediatric patients undergoing cardiac surgery presents unique challenges due to limited therapeutic options.
• Current anticoagulants pose risks, necessitating alternative strategies for HIT patients requiring cardiopulmonary bypass.

Observation:

• A report on the management of a pediatric patient with HIT necessitating cardiac surgery.
• The case involves an infant with HIT who required a bidirectional Glenn shunt procedure.
• The patient presented with a complex cardiac condition alongside HIT.

Findings:

• Successful anticoagulation management was achieved using lepirudin (a direct thrombin inhibitor) during cardiac surgery.
• Lepirudin provided an alternative anticoagulant option for this pediatric HIT patient.
• Anticoagulation monitoring and precise dosing of lepirudin proved difficult in this clinical scenario.

Implications:

• This case demonstrates the potential utility of lepirudin in pediatric HIT patients undergoing cardiac surgery.
• The findings underscore the critical need for reliable monitoring methods for lepirudin to ensure safe and effective anticoagulation.
• Further research is warranted to establish standardized protocols for lepirudin use in pediatric cardiac surgery for HIT management.